These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30546)

  • 21. Pharmacologic therapy for urticaria.
    Negro-Alvarez JM; Carreño-Rojo A; Funes-Vera E; García-Cánovas A; Abellán-Alemán AF; Rubio del Barrio R
    Allergol Immunopathol (Madr); 1997; 25(1):36-51. PubMed ID: 9111875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists.
    Lin RY; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    Ann Emerg Med; 2000 Nov; 36(5):462-8. PubMed ID: 11054200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy of four antihistamines in chronic urticaria.
    Youngchaiyud U
    J Med Assoc Thai; 1988 Oct; 71(10):548-52. PubMed ID: 2907911
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of cold urticaria.
    Highet AS; Titterington DM
    Br J Dermatol; 1979 Jul; 101(1):51-5. PubMed ID: 475987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediator release in local heat urticaria: protection with combined H1 and H2 antagonists.
    Irwin RB; Lieberman P; Friedman MM; Kaliner M; Kaplan R; Bale G; Treadwell G; Yoo TJ
    J Allergy Clin Immunol; 1985 Jul; 76(1):35-9. PubMed ID: 2861221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H1- and H2-antagonists in allergic and pseudoallergic diseases.
    Ring J; Behrendt H
    Clin Exp Allergy; 1990 Aug; 20 Suppl 2():43-9. PubMed ID: 1977507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists.
    Hatakeyama M; Fukunaga A; Washio K; Ogura K; Yamada Y; Horikawa T; Nishigori C
    J Dermatol Sci; 2016 May; 82(2):137-9. PubMed ID: 26896422
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of cluster headache with histamine H1 and H2 receptor antagonists.
    Cuypers J; Altenkirch H; Bunge S
    Eur Neurol; 1979; 18(5):345-7. PubMed ID: 43254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study].
    Diller G; Orfanos CE
    Z Hautkr; 1983 Jun; 58(11):785-93. PubMed ID: 6136132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic idiopathic urticaria treatment.
    Negro-Alvarez JM; Miralles-López JC
    Allergol Immunopathol (Madr); 2001; 29(4):129-32. PubMed ID: 11674926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired cold urticaria: H1 and H2 antagonists versus cold induced histamine release.
    Katayama I; Doi T; Nishioka K; Maeyama K; Yamatodani A
    J Dermatol; 1983 Aug; 10(4):377-82. PubMed ID: 6199393
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihistamines in urticaria and angioedema.
    Black AK; Greaves MW
    Clin Allergy Immunol; 2002; 17():249-86. PubMed ID: 12113219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic idiopathic urticaria unresponsive to type 1 antihistamines in monotherapy].
    Mateus C
    Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S129-44. PubMed ID: 12843818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urticaria: current therapy.
    Soter NA
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1009-14. PubMed ID: 1979795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria.
    Beck LA; Bernstein JA; Maurer M
    Acta Derm Venereol; 2017 Feb; 97(2):149-158. PubMed ID: 27349620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation and treatment of chronic urticaria.
    Fonacier L; Aquino M; Kim B
    Postgrad Med; 2010 Mar; 122(2):148-56. PubMed ID: 20203466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.
    Simons FE; Sussman GL; Simons KJ
    J Allergy Clin Immunol; 1995 Mar; 95(3):685-93. PubMed ID: 7897151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of urticaria. An evidence-based evaluation of antihistamines.
    Lee EE; Maibach HI
    Am J Clin Dermatol; 2001; 2(1):27-32. PubMed ID: 11702618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [H2-antihistamines (cimetidine) in allergic-inflammatory reactions].
    Permin H; Norn S; Skov PS
    Ugeskr Laeger; 1980 Apr; 142(18):1133-5. PubMed ID: 6105734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.